Susan Dexter serves as Executive at Sonnet BioTherapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Susan Dexter has executed 9 insider transactions totaling $7.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 2, 2025 involved selling 9,643 shares valued at $0.
Susan Dexter currently holds 9,643 shares of Sonnet BioTherapeutics Holdings, Inc. (SONN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Susan Dexter has been a net buyer of SONN stock. They have purchased $7.0K and sold $0 worth of shares.
Susan Dexter's most recent insider trade was on Dec 2, 2025, when they sold 9,643 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 14, 2023 | SONN | $7.0K | Purchase | 10,000 | $0.70 | Discretionary |
| Jan 7, 2023 | SONN | $0 | Award | 14,627 | $N/A | Discretionary |
| Jan 7, 2023 | SONN | $0 | Disposition | 14,627 | $N/A | Discretionary |
| Dec 14, 2022 | SONN | $0 | Award | 14,627 | $N/A | Discretionary |
| Dec 15, 2021 | SONN | $0 | Award | 63,104 | $N/A | Discretionary |
| May 25, 2021 | SONN | $15.3K | Payment | 10,145 | $1.51 | Discretionary |
| Jul 2, 2020 | SONN | $0 | Award | 73,613 | $N/A | Discretionary |